Vazirani Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Vazirani Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,000	Closed	-$1.39M	–	36
2023 Q2	$1.39M	Buy	+30,000	New	+$1.04M	2.35%	14

Vazirani Asset Management's DICE Position: Q3 2023 in Review

Vazirani Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 30,000 shares — an estimated $1.39M sold.

Vazirani Asset Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.39M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Vazirani Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Vazirani Asset Management sold 30,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.39M.
Vazirani Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Vazirani Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $1.39M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Vazirani Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.